About Milson

Milson represents private and public companies and investment banks in various capital markets and corporate transactions, including initial public offerings, follow-on and secondary offerings, debt offerings and SPAC mergers. Milson also counsels public companies on a full range of corporate and securities matters, including SEC reporting obligations and corporate governance.

Milson’s recent representative transactions include advising:

  • Instacart on its $660 million IPO
  • Confluent on its $828 million IPO and its $1.1 billion Rule 144A convertible notes offering
  • 1Life Healthcare (One Medical) on its:
    • $281.8 million IPO
    • $275 million Rule 144A convertible notes offering
    • $2.1 billion all-stock acquisition of Iora Health
  • Thayer Ventures on its $1.1 billion deSPAC business combination with Inspirato
  • Opthea on its $128 million IPO
  • Docebo on its $165.6 million IPO and multiple secondary offerings
  • Absolute Software on its $69 million IPO and its $340 million cash acquisition of NetMotion
  • The underwriters on AssetMark’s $316 million IPO
  • NVIDIA on registered notes offerings raising $10 billion in aggregate
  • Jazz Pharmaceuticals on its $1 billion Rule 144A exchangeable notes offering
Download full bio

Education

  • Cornell Law School
    JD, cum laude, 2013
  • Samuel Curtis Johnson Graduate School of Management, Cornell University
    MBA, with distinction, 2013
  • Georgia Institute of Technology
    BSM, magna cum laude, 2010

Rankings and accolades

Chambers USA: Capital Markets: Debt & Equity: Western United States – Nationwide (2024 – 2025)

Chambers USA: Up and Coming for Capital Markets: Debt & Equity – California (2024 – 2025)

Law360: Rising Stars of 2024

The Legal 500 US: Capital Markets: Equity Offerings (2025)